🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06256614
Recruiting Observational

Washed Microbiota Transplantation for Type 1 Diabetes Mellitus

NCT06256614 · tracked via the Priya Life Science China tracker
Sponsor
The Second Hospital of Nanjing Medical University
Phase
Observational
Started
2024-03-01
Last updated
2025-09-10

Condition(s) studied

Type 1 Diabetes

Investigational drug(s) / intervention(s)

WMT

WMT: Washed microbiota transplantation refers to the infusion of washed microbiota from healthy donor into patients' gastrointestinal tract. Participants will receive three doses of WMT for T1DM.

Study summary

This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation (WMT) for patients with Type 1 Diabetes Mellitus (T1DM).

Eligibility

Sex
ALL
Min age
3 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: Subjects must meet all of the following inclusion criteria to enter the study: 1. At the time of informed consent, male or non-pregnant or non-lactating female. 2. The diagnostic criteria for T1DM are confirmed by previous medical record. 3. The subject or his/her legal representative gives informed consent, fully nderstands the purpose of the study, is able to communicate effectively with the investigator, and comprehends and complies with the requirements set forth in the study. Exclusion Criteria: Subjects meeting any of the following exclusion criteria must be excluded from the study: 1. Diagnosed as any type of diabetes other than type 1 diabetes mellitus; 2. Subjects with severe life-threatening complications diabetes (such as ketoacidosis, or acute coronary syndrome, etc.); 3. At the time of screening, the subject or his/her legal representative refuses to take effective contraception within 3 months after the last treatment. 4. According to the judgment of the investigator, the subjects are not suitable to participate in this clinical study, or participation in this clinical study cannot guarantee the rights and interests of the subjects.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu Recruiting

More The Second Hospital of Nanjing Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06256614 on ClinicalTrials.gov ↗ ← All trials in China